DF Dent & Co’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-75,000
| Closed | -$10.9K | – | 273 |
|
|
2025
Q1 | $10.9K | Buy |
+75,000
| New | +$10.9K | ﹤0.01% | 259 |
|
|
2024
Q4 | – | Sell |
-75,000
| Closed | -$9K | – | 271 |
|
|
2024
Q3 | $9K | Buy |
+75,000
| New | +$9K | ﹤0.01% | 261 |
|
|
2024
Q2 | – | Sell |
-75,000
| Closed | -$30K | – | 271 |
|
|
2024
Q1 | $30K | Buy |
+75,000
| New | +$30K | ﹤0.01% | 263 |
|
|
2023
Q4 | – | Sell |
-75,000
| Closed | -$39.4K | – | 275 |
|
|
2023
Q3 | $39.4K | Hold |
75,000
| – | – | ﹤0.01% | 253 |
|
|
2023
Q2 | $14.3K | Buy |
+75,000
| New | +$29.5K | ﹤0.01% | 255 |
|
|
2022
Q2 | – | Sell |
-75,000
| Closed | -$94K | – | 261 |
|
|
2022
Q1 | $94K | Buy |
+75,000
| New | +$116K | ﹤0.01% | 256 |
|
|
2014
Q3 | – | Sell |
-22,500
| Closed | -$111K | – | 171 |
|
|
2014
Q2 | $111K | Buy |
+22,500
| New | +$116K | ﹤0.01% | 166 |
|
|
2014
Q1 | – | Sell |
-15,000
| Closed | -$91K | – | 237 |
|
|
2013
Q4 | $91K | Hold |
15,000
| – | – | ﹤0.01% | 252 |
|
|
2013
Q3 | $99K | Hold |
15,000
| – | – | ﹤0.01% | 159 |
|
|
2013
Q2 | $76K | Buy |
+15,000
| New | +$76K | ﹤0.01% | 155 |
|
Other funds holding NYMX
DF Dent & Co's NYMX Position: Q2 2025 in Review
DF Dent & Co sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2025, closing a stake of 75,000 shares — an estimated $10.9K sold.
DF Dent & Co first reported a position in NYMX in Q2 2013 and held it in 10 quarters. The position peaked at $111K in Q2 2014. 1 fund tracked by Wall St. Rank holds NYMX as of Q2 2025.
- DF Dent & Co reported no remaining Nymox Pharmaceutical Corp position as of Q2 2025 after selling out during the quarter.
- DF Dent & Co sold 75,000 Nymox Pharmaceutical Corp shares in Q2 2025, an estimated $10.9K.
- DF Dent & Co first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 10 quarters.
- DF Dent & Co's Nymox Pharmaceutical Corp position peaked at $111K in Q2 2014.
- 1 fund tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2025.
Based on DF Dent & Co's 13F filing for Q2 2025, filed 14 Aug 2025.